|Bid||1.86 x 12700|
|Ask||1.87 x 4600|
|Day's Range||1.85 - 1.95|
|52 Week Range||1.02 - 2.63|
|PE Ratio (TTM)||-7.12|
|Earnings Date||Nov 8, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||7.75|
LONDON, UK / ACCESSWIRE / October 13, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Athersys, Inc. (NASDAQ: ATHX ), following which we have published ...
NEW YORK, NY / ACCESSWIRE / October 12, 2017 / All three major indexes closed at record highs Wednesday after minutes from the most recent Federal Reserve Meeting suggested a December rate hike was not ...
CLEVELAND, Oct. 11, 2017-- Athersys, Inc. today announced that it has entered into a manufacturing services agreement with Nikon CeLL innovation Co., Ltd. for commercial production of its stem cell therapy, ...
CLEVELAND, Oct. 09, 2017-- Athersys, Inc. will release its third quarter 2017 financial results at approximately 4:00 PM Eastern Time on Wednesday, November 8, 2017, and will host a conference call shortly ...
CLEVELAND, Oct. 05, 2017-- Athersys, Inc. announced today that Robert W. Mays, Ph.D., Vice President, Regenerative Medicine and Head of Neuroscience Programs, will present at the annual Partnering Forum ...